Phase
Condition
Lung Injury
Respiratory Failure
Treatment
Dexmedetomidine
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject is acutely mechanically ventilated during the current hospitalization.
Subject is currently receiving a continuous intravenous infusion of asedative/opioid medication(s) or has received at least one intravenous bolus dose ofa sedative/opioid medication in the previous 24 hours (fentanyl, hydromorphone,ketamine, morphine, midazolam, diazepam, lorazepam, propofol, haloperidol,dexmedetomidine).
Subject must pass pre-Patient-Controlled Sedation (PCS) screening test and beassessed Richmond Agitation-Sedation Scale (RASS) -2 to +1
Subject Age ≥ 18 years
Subject or their proxy is capable of providing informed consent
Exclusion
Exclusion Criteria:
Aggressive ventilatory support or prone ventilation.
Hypotension (systolic blood pressure < 85 mmHg) requiring a vasopressor at a dosegreater than norepinephrine or epinephrine 0.15 mcg/kg/min or vasopressin > 2.4units per hour. Subjects will be excluded if they require more than one continuousinfusion of a catecholamine vasopressor medication simultaneously. Subjects will beexcluded if the vasopressor dose was higher than norepinephrine or epinephrine 0.15mcg/kg/min, vasopressin > 2.4 units per hour, phenylephrine >3 mcg/kg/min, dopamine >10 mcg/kg/min or dobutamine at any dose in the prior 6 hours. If dopamine is beingused to increase heart rate, rather than as a vasopressor for hypotension, subjectwill be excluded.
Second or third degree heart block or bradycardia (heart rate < 50 beats/min).
Paralysis or other condition preventing the use of push button device
Positive pregnancy test or lactation
Acute hepatitis or liver failure (direct bilirubin >5 mg/dL)
Acute stroke or uncontrolled seizures.
Acute myocardial infarction within 48 hours prior to enrollment.
Severe cognition or communication problems (such as coma, deafness without signingliteracy, physician-documented dementia)
Assessed RASS -3, -4, -5 or RASS +2,+3, +4
Chronic ventilator support in place of residence prior to current hospitalization.
Imminent extubation from mechanical ventilator support.
Study Design
Study Description
Connect with a study center
School of Medicine, University of Minnesota
Minneapolis, Minnesota 55455
United StatesSite Not Available
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.